Pacira Biosciences Inc banner

Pacira Biosciences Inc
F:82P

Watchlist Manager
Pacira Biosciences Inc Logo
Pacira Biosciences Inc
F:82P
Watchlist
Price: 20 EUR 1.01% Market Closed
Market Cap: €931m

Wall St Price Targets

82P Price Targets Summary
Pacira Biosciences Inc

Wall Street analysts forecast 82P stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 82P is 21.38 EUR with a low forecast of 16.22 EUR and a high forecast of 29.13 EUR.

Lowest Forecast
Price Target
16.22 EUR
19% Downside
Average Forecast
Price Target
21.38 EUR
7% Upside
Highest Forecast
Price Target
29.13 EUR
46% Upside
Pacira Biosciences Inc Competitors:
Price Targets

Revenue
Forecast

25% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
25% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 0%.

Operating Income
Forecast

N/A
Past Growth
49% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss
N/A
Past Growth
49% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss

The compound annual growth rate for Operating Income over the next 5 years is 49%.

Net Income
Forecast

N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-64%
Average Miss
N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-64%
Average Miss

The compound annual growth rate for Net Income over the next 7 years is 58%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 82P's stock price target?
Price Target
21.38 EUR

According to Wall Street analysts, the average 1-year price target for 82P is 21.38 EUR with a low forecast of 16.22 EUR and a high forecast of 29.13 EUR.

What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
0%

Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 0%.

What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
49%

The compound annual growth rate for Operating Income over the next 5 years is 49%.

What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
58%

The compound annual growth rate for Net Income over the next 7 years is 58%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett